发明名称 4-FLUORO-N-INDAN-2-YL BENZAMIDE AND ITS USE AS PHARMACEUTICAL.
摘要 <p>The present invention relates to the method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan-2-yl benzamide according to the formula (I)to the said mammal. The compound (I) can be used for the therapy and prophylaxis of cardiovascular diseases like stable and unstable angina pectoris, Prinzmetal angina (spasm), acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis, peripheral artery occlusive disease PAOD, atherosclerosis, restenosis, endothelial damage after PTCA, essential hypertension, pulmonary hypertension, secondary hypertension, renovascular chronic glomerulonephritis, erectile dysfunction, ventricular arrhythmia, and the lowering of cardiovascular risk of postmenopausal women or after intake of contraceptives, the therapy and prophylaxis of diabetes and diabetes complications (nephropathy, retinopathy), angiogenesis, asthma bronchiale, chronic renal failure, cirrhosis of the liver, restricted memory performance or a restricted ability to learn.</p>
申请公布号 MXPA03006841(A) 申请公布日期 2003.11.13
申请号 MX2003PA06841 申请日期 2002.02.12
申请人 AVENTIS PHARMA DEUTSCHLAND GMBH 发明人 HARTMUT STROBEL
分类号 A61K31/00;A61K31/166;A61K31/66;A61P1/16;A61P5/48;A61P7/02;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/12;A61P15/10;A61P19/10;A61P25/28;A61P27/06;A61P43/00;C07C233/65;(IPC1-7):A61K31/66 主分类号 A61K31/00
代理机构 代理人
主权项
地址